Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  6,700 نتائج ل ""Antiviral""

فلترة النتائج

Subject : covid-19 فلترة بواسطة : موضوع
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal mechanistic insights.

  • Authors : Watson A; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center San Antonio, San Antonio, Texas, United States of America.; Shah P

Subjects: Valproic Acid*/Valproic Acid*/Valproic Acid*/pharmacology ; Valproic Acid*/Valproic Acid*/Valproic Acid*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: PloS one [PLoS One] 2024 Aug 02; Vol. 19 (8), pp. e0307154. Date of Electronic Publication: 2024 Aug 02 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2.

  • Authors : Saikh KU; GlycoMantra Inc., bwtech South of the University of Maryland Baltimore County, 1450 South Rolling Road, Baltimore, MD 21227, USA.; Anam K

Subjects: Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/metabolism ; Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/Myeloid Differentiation Factor 88*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/physiology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Aug 01; Vol. 25 (15). Date of Electronic Publication: 2024 Aug 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody.

  • Authors : Maruyama S; Department of Emergency and Critical Care Medicine, Kansai Medical University General Medical Center, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8507, Japan.; Wada D

Subjects: Virus Shedding*/Virus Shedding*/Virus Shedding*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 22; Vol. 24 (1), pp. 715. Date of Electronic Publication: 2024 Jul 22.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and Safety of Azvudine in Patients With COVID-19 in China: A Meta-Analysis of Observational Studies.

  • Authors : Dong T; Pharmacy Department, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing, China.; Zhang W

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/adverse effects ; COVID-19*/COVID-19*/COVID-19*/mortality

  • Source: The clinical respiratory journal [Clin Respir J] 2024 Jul; Vol. 18 (7), pp. e13798.Publisher: Blackwell Publishing Country of Publication: England NLM ID: 101315570 Publication Model: Print Cited Medium: Internet ISSN: 1752-699X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Is Antiviral Treatment with Remdesivir at the Acute Phase of SARS-CoV-2 Infection Effective for Decreasing the Risk of Long-Lasting Post-COVID Symptoms?

  • Authors : Fernández-de-Las-Peñas C; Department of Physical Therapy, Occupational Therapy, Physical Medicine and Rehabilitation, Universidad Rey Juan Carlos, 28922 Madrid, Spain.; Center for Neuroplasticity and Pain (CNAP), Sensory-Motor Interaction (SMI), Department of Health Science and Technology, Faculty of Medicine, Aalborg University, DK 9220 Aalborg, Denmark.

Subjects: Alanine*/Alanine*/Alanine*/analogs & derivatives ; Alanine*/Alanine*/Alanine*/therapeutic use ; Alanine*/Alanine*/Alanine*/administration & dosage

  • Source: Viruses [Viruses] 2024 Jun 12; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Identification and Analysis of Biomarkers Associated with Lipophagy and Therapeutic Agents for COVID-19.

  • Authors : Wu Y; Institute of Tropical Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510405, China.; Wu Z

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/drug effects ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/physiology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics

  • Source: Viruses [Viruses] 2024 Jun 07; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 07.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study.

  • Authors : Rotundo S; Dipartimento di Scienze Mediche e Chirurgiche, Università 'Magna Graecia', Catanzaro, Italy. .; Berardelli L

Subjects: Immunocompromised Host* ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/mortality

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Jun 06; Vol. 24 (1), pp. 564. Date of Electronic Publication: 2024 Jun 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Molecular Research on Coronavirus: Pathogenic Mechanisms, Antiviral Drugs, and New Vaccines.

  • Authors : Zhang M; National Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.; Lang Y

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 04; Vol. 25 (11). Date of Electronic Publication: 2024 Jun 04.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: Emerging infectious diseases [Emerg Infect Dis] 2024 Jun; Vol. 30 (6), pp. 1289-1291. Date of Electronic Publication: 2024 Apr 26.Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Real-world evaluation of early remdesivir in high-risk COVID-19 outpatients during Omicron including BQ.1/BQ.1.1/XBB.1.5.

  • Authors : Molina KC; Department of Emergency Medicine, University of Colorado School of Medicine, 12401 E. 17th Ave, Aurora, CO, B-215, 80045, USA. .; Department of Pharmacy, Scripps Health, San Diego, CA, 92037, USA. .

Subjects: Alanine*/Alanine*/Alanine*/analogs & derivatives ; Alanine*/Alanine*/Alanine*/therapeutic use ; Adenosine Monophosphate*/Adenosine Monophosphate*/Adenosine Monophosphate*/analogs & derivatives

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 08; Vol. 24 (1), pp. 802. Date of Electronic Publication: 2024 Aug 08.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  6,700 نتائج ل ""Antiviral""